Standard BioTools Inc. (NASDAQ: LAB) (the 'Company” or 'Standard BioTools”) today announced financial results for the quarter and fiscal year ended December 31, 2025.
View original content to download multimedia:https://www.prnewswire.com/news-releases/improved-cash-flow-highlights-cooper-standards-fourth-quarter-and-full-year-2023 ...
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the “Company”) today announced preliminary and unaudited revenue results for the fourth quarter ...
BOSTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (NASDAQ: LAB) today announced that it will publish fourth quarter and full year 2025 financial results on Tuesday, February 24, ...